financetom
Business
financetom
/
Business
/
Centerspace Q4 Core FFO Slips, Revenue Rises; 2025 Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centerspace Q4 Core FFO Slips, Revenue Rises; 2025 Guidance Set
Feb 18, 2025 3:21 PM

05:58 PM EST, 02/18/2025 (MT Newswires) -- Centerspace ( CSR ) reported Q4 core funds from operations late Tuesday of $1.21 per diluted share, down from $1.22 a year earlier.

Analysts polled by FactSet expected $1.19.

Revenue for the quarter that ended Dec. 31 was $66.4 million, up from $64.1 million a year earlier.

Analysts surveyed by FactSet expected $65.8 million.

The company expects a 2025 core FFO of $4.86 to $5.10 per diluted share. Analysts surveyed by FactSet expect $4.92.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Levi Strauss & Co Insider Sold Shares Worth $460,986, According to a Recent SEC Filing
Levi Strauss & Co Insider Sold Shares Worth $460,986, According to a Recent SEC Filing
Apr 1, 2024
08:19 AM EDT, 04/01/2024 (MT Newswires) -- Bradley J. Haas, 10% Owner, on March 28, 2024, sold 23,041 shares in Levi Strauss & Co ( LEVI ) for $460,986. SEC Filing: https://www.sec.gov/Archives/edgar/data/94845/000093583624000326/xslF345X03/ownership.xml Price: 20, Change: +0.01, Percent Change: +0.05 ...
Antibe Therapeutics Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Antibe Therapeutics Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Apr 1, 2024
08:26 AM EDT, 04/01/2024 (MT Newswires) -- Antibe Therapeutics Inc. ( ATBPF ) , which gained more than 4.5% last Thursday, on Monday announced that it received verbal notice from the U.S. Food and Drug Administration on March 28 that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial. Antibe expects to receive...
Sector Update: Consumer
Sector Update: Consumer
Apr 1, 2024
08:21 AM EDT, 04/01/2024 (MT Newswires) -- Consumer stocks were leaning higher pre-bell Monday with the Consumer Staples Select Sector SPDR Fund (XLP) recently inactive, while the Consumer Discretionary Select Sector SPDR Fund (XLY) was up 0.1%. Doma Holdings ( DOMA ) rose more than 35% after announcing its pending takeover by Title Resources Group for $6.29 per share in...
Top Premarket Decliners
Top Premarket Decliners
Apr 1, 2024
08:19 AM EDT, 04/01/2024 (MT Newswires) -- Fractyl Health ( GUTS ) shares fell 19% Monday premarket after the company reported a wider Q4 net loss. CalciMedica ( CALC ) shares dropped 18% following a muted session. Vivos Therapeutics ( VVOS ) shares decreased by 17% after the company late Thursday reported lower annual revenue for the year ended Dec....
Copyright 2023-2026 - www.financetom.com All Rights Reserved